跳至主要内容
临床试验/PACTR2008060000861040
PACTR2008060000861040已完成未知

An international multicentre controlled clinical trial to evaluate high dose rifapentine and a quinolone in the treatment of pulmonary tuberculosis

St Georges Hospital Medical School trading as St Georges University of London0 个研究点目标入组 1,100 人开始时间: 2008年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Newly diagnosed pulmonary tuberculosis
  • 2. Two sputum specimens positive for tubercle bacilli on direct smear microscopy
  • 3. Either no previous anti-tuberculosis chemotherapy, or less than two weeks of previous chemotherapy
  • 4. Aged 18 years and over
  • 5. A firm home address that is readily accessible for visiting and be intending to remain there during the entire treatment and follow up period
  • 6. Willing to agree to participate in the study and to give a sample of blood for HIV testing

排除标准

  • 1. Has any condition (except HIV infection) that may prove fatal during the study period
  • 2. Has Tuberculous (TB) meningitis
  • 3. Has pre-existing non-tuberculous disease likely to prejudice the response to, or assessment of, treatment e.g., insulin-dependent diabetes, liver or kidney disease, blood disorders, peripheral neuritis
  • 4. Is female and known to be pregnant, or breast feeding
  • 5. Is suffering from a condition likely to lead to uncooperative behaviour such as psychiatric illness or

研究者

发起方
St Georges Hospital Medical School trading as St Georges University of London

相似试验